250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Biotechnology VC (Venture Capital) Funds in Israel in October 2023

A list of 50 VC (Venture Capital) funds that invest in Biotechnology startups based in Israel. We rank investors based on the number of investments they made in Biotechnology companies from Israel. We update this investor list every month.

Top 50 Biotechnology VC (Venture Capital) Funds in Israel in October 2023

Investor Biotechnology Israel investments
Pontifax 18
Trendlines Group 16
OurCrowd 9
Israel Innovation Authority 8
Docor International Management 7
OrbiMed 7
HBL Hadasit Bio Holdings 6
Arkin Holdings 6
aMoon Fund 5
ZORA Ventures 4
iAngels 4
Clal Biotechnology Industries 4
Takeda Ventures 4
Johnson & Johnson Robotics and Digital Solutions 4
Accelmed 4
Integra Holdings 4
Triventures 3
Ziegler Meditech Equity Partners 3
Sapir Venture Partners 3
S2G Ventures 3
SciSparc 3
Binder & Partners Ventures 3
FutuRx 3
Pitango VC 3
Welltech Ventures 3
Millenium Food-Tech 3
Office of the Chief Scientist 3
Neo Ventures 3
Bits x Bites 2
fresh.fund 2
NFX 2
Jerusalem Global Ventures 2
HackCapital 2
ALIVE Israel HealthTech Fund 2
BRM Capital 2
Good Seed Ventures 2
RMGP Biopharma Investment Fund 2
Elron Ventures 2
Fortissimo Capital 2
Flerie Invest 2
Genesis Park 2
GlenRock Israel 2
Yozma Group 2
SCP Vitalife Partners 2
NFX Bio 2
Tyson Ventures 2
Amplifyher Ventures 2
Milk & Honey Ventures 2
HealthpointCapital 2
Aurum Ventures MKI 2

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 1 investment in the past 12 months

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Israel, France

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
  • ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Show more investments...

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 2 investments in the past 12 months

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Seed, Funding Round, Series A
  • Israel, Singapore, United Kingdom

Portfolio highlights

  • Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
  • Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
  • PlanetWatchers — Highly accurate crop growth, wind, hail and flood damage assessments at scale. Supporting the crop insurance industry with acreage and claims validation.
Show more investments...

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 14 investments in the past 12 months

Access exclusive VC angel investment deals in pre-vetted startup companies. Join now.

Show more...

Investment focus

  • Software, Artificial Intelligence, Machine Learning
  • Series B, Series A, Seed
  • Israel, United States, Canada

Portfolio highlights

  • ThetaRay — ThetaRay's big data analytics solutions are based on AI & machine learning, empowering businesses to find opportunities and threats hidden in their big data
  • Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
  • Intuition Robotics — Intuition Robotics empowers older adults to live happier, healthier and independent lives at home with an empathetic digital companion, ElliQ.
Show more investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 4 investments in the past 12 months

The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Health Care, Medical Device, Software
  • Grant, Seed, Pre-Seed
  • Israel, United States, Mali

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • BloomX — Helping nature do its magic with the power of technology
  • MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Show more investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Health Care, Biotechnology, Pharmaceutical
  • Funding Round, Series C, Series A
  • Israel, United States

Portfolio highlights

  • Check-Cap — The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
  • Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Show more investments...

OrbiMed
VC Fund · New York, New York, United States · 38 investments in the past 12 months

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, China, Israel

Portfolio highlights

  • Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
  • Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
  • Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
Show more investments...

HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Funding Round, Series A, Series B
  • Israel

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show more investments...

Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 5 investments in the past 12 months

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical Device
  • Series A, Seed, Funding Round
  • Israel, United States, Switzerland

Portfolio highlights

  • Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
  • MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
  • Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
Show more investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel

aMoon is a leading healthtech & life sciences venture capital firm.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Funding Round, Series A, Series B
  • United States, Israel, United Kingdom

Portfolio highlights

  • Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
  • Eleos Health — Eleos Health provides automated health tech solutions that accelerate clinicians’ decision-making via an AI-powered Speech-to-Insights system to ensure the provision of personalized and time and cost-effective care.
  • Ultima Genomics — Ultima Genomics, Inc is revolutionizing DNA sequencing technology with the UG100 by providing scalability for the $100 genome
Show more investments...

ZORA Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investment in the past 12 months

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Show more...

Investment focus

  • Health Care, Biotechnology, Internet
  • Seed, Series A, Convertible Note
  • Israel, United States, United Kingdom

Portfolio highlights

  • BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
  • EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
  • Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Show more investments...

iAngels
VC Fund · Tel Aviv, Tel Aviv, Israel · 5 investments in the past 12 months

iAngels is a VC and angel investment platform that leverages due diligence and analytics to enable accredited investors around the world the ability to invest in early-stage technology deals in Israel.

Show more...

Investment focus

  • Artificial Intelligence, Software, FinTech
  • Seed, Series A, Funding Round
  • United States, Israel, United Kingdom

Portfolio highlights

  • Guardz — Ultimate cybersecurity solution built for MSPs, IT pros, & business owners. Protect your clients & business with an all-in-one security & monitoring solution.
  • CoinScan — Fastest trading history in the industry for any ETH token along with seeing pending transactions. One-of-a-kind Airdrops and Holders distribution for quick analysis and much more.
  • Nest Genomics (YC W22) — Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.
Show more investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • Israel, United States

Portfolio highlights

  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
  • Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Show more investments...

Takeda Ventures
VC Fund · San Diego, California, United States · 6 investments in the past 12 months

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Funding Round
  • United States, United Kingdom, Israel

Portfolio highlights

  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
  • Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Show more investments...

Johnson & Johnson Robotics and Digital Solutions
VC Fund · New Brunswick, New Jersey, United States · 3 investments in the past 12 months

Healthcare innovation wherever it originates.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Israel, United Kingdom

Portfolio highlights

  • Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
  • ArteraAI — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
  • Nucleome Therapeutics — Decoding the dark matter of the human genome to deliver first-in-class precision medicinesDiscover More
Show more investments...

Accelmed
VC Fund · Aventura, Florida, United States · 2 investments in the past 12 months

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

Show more...

Investment focus

  • Health Care, Medical Device, Medical
  • Funding Round, Series D, Series A
  • Israel, United States

Portfolio highlights

  • Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
  • Minerva Surgical — Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
  • Click Therapeutics — A biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. Learn more.
Show more investments...

Integra Holdings
VC Fund · Wallisellen, Zurich, Switzerland

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Show more...

Investment focus

  • Biotechnology, Pharmaceutical, Life Science
  • Seed, Series B, Series F
  • Israel

Portfolio highlights

  • BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
  • Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
  • Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Show more investments...

Triventures
VC Fund · Herzliya, Tel Aviv, Israel · 1 investment in the past 12 months

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

Show more...

Investment focus

  • Health Care, Medical Device, Medical
  • Funding Round, Series B, Seed
  • United States, Israel, Ireland

Portfolio highlights

  • FEMSelect — More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.
  • Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
  • Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.
Show more investments...

Ziegler Meditech Equity Partners
VC Fund · Milwaukee, Wisconsin, United States

ZMEP is a limited partnership focusing on equity and equity-like investments in emerging medical device technologies. ZMEP invests globally drawing on the years of investing experience of its management team. With over 50 years of experience in medical device development and commercialization, the ZMEP management team has the ability to seek outand partner with leading entrepreneurs in the medical device field. With offices in the United States and Israel, ZMEP is positioned globally to partner with middle to late stage medical device companies showing great promise for success through commercialization.

Show more...

Investment focus

  • Health Care, Biotechnology, Mobile
  • Series C, Series E, Series F
  • United States, Israel

Portfolio highlights

  • Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
  • MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
  • MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Show more investments...

Sapir Venture Partners
VC Fund

Early Stage VC

Show more...

Investment focus

  • Software, Biotechnology, Machine Learning
  • Seed, Pre-Seed, Series A
  • Israel, United States, United Kingdom

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
  • Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
Show more investments...

S2G Ventures
VC Fund · Chicago, Illinois, United States · 15 investments in the past 12 months

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Food and Beverage, Agriculture, Biotechnology
  • Series A, Series B, Seed
  • United States, Canada, Israel

Portfolio highlights

  • MEND — Mend is the scientifically proven way to heal and enhance your body faster.
  • TechMet — TechMet Ltd backs world-class teams and makes direct investments into companies and assets across the value chain.
  • Electric Hydrogen — Electric Hydrogen designs and builds low-cost, high-efficiency green hydrogen systems to economically decarbonize industrial sectors like ammonia and steel
Show more investments...

SciSparc
VC Fund · Giv'atayim, Tel Aviv, Israel · 1 investment in the past 12 months

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.

Show more...

Investment focus

  • Pharmaceutical, Cannabis, Biopharma
  • Funding Round, Corporate Round
  • Israel

Portfolio highlights

  • LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
  • MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.
Show more investments...

Binder & Partners Ventures
VC Fund · Paris, Ile-de-France, France · 1 investment in the past 12 months

Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Series A
  • Israel, France, United States

Portfolio highlights

  • Rookout — Speed up the debugging process and accelerate your team's velocity with Rookout's live, remote debugging platform. Debug anything, anywhere. Effortlessly.
  • Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
  • Blink Technologies — Blink creates the ultimate interaction between your eyes & the world around you with our eye tracking software & eye tracking technology.
Show more investments...

FutuRx
VC Fund · Ness Ziona, HaMerkaz, Israel

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Show more...

Investment focus

  • Health Care, Biotechnology, Pharmaceutical
  • Funding Round
  • Israel

Portfolio highlights

  • Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
  • Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
  • Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
Show more investments...

Pitango VC
VC Fund · Herzliya, Tel Aviv, Israel · 20 investments in the past 12 months

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Series A, Series B, Series C
  • Israel, United States, China

Portfolio highlights

  • AI21 Labs — AI21 Labs is an AI lab & product company whose mission is to reimagine the way we read and write by making the machine a thought partner to humans.
  • QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.
  • Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Show more investments...

Welltech Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel

Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.

Show more...

Investment focus

  • mHealth, Health Care, Biotechnology
  • Seed, Funding Round, Pre-Seed
  • Israel, United States

Portfolio highlights

  • Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
  • AMKIRI — Amkiri has scientifically developed a Brand New product category for the beauty industry which combines the senses of smell and sight, and enables the complete freedom of multi-sensory self-expression.
  • Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Show more investments...

Millenium Food-Tech
VC Fund

Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.

Show more...

Investment focus

  • Food and Beverage, Manufacturing, Agriculture
  • Seed, Series A, Convertible Note
  • Israel

Portfolio highlights

  • Tipa — Tipa has developed breakthrough 100% biodegradable and compostable flexible packaging solutions for food and beverages. Imitating nature’s and just like an orange peel, their packaging solutions bring a new generation of packaging that easily biodegrade post-consumption and reduce dramatically their impact on the environment.Ranging from simpleone-ply films to complex multi-layer products, their packaging solutions offer a combination of superior properties in almost every aspect including high yield, flexibility, transparency, impact strength, and barrier properties.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Supersmart — Supersmart is the world's leading loss-prevention solution for self-scan transactions. Supersmart uses its proprietary machine-learning, AI algorithm to validate all self-scanning transactions in physical stores. Our solution enables retailers to confidently provide self-scanning options to their customers, enhancing customer experiencewithout sacrificing potential loss.The Israel-based company was founded in 2014 by Yair Cleper and Amir Ayalon.
Show more investments...

Office of the Chief Scientist
VC Fund · Tel Aviv, Tel Aviv, Israel

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

Show more...

Investment focus

  • Health Care, Biotechnology, Hardware
  • Seed
  • Israel

Portfolio highlights

  • LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
  • Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
  • Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
Show more investments...

Neo Ventures
VC Fund · Sofia, Grad Sofiya, Bulgaria

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

Show more...

Investment focus

  • Software, Artificial Intelligence, Aerospace
  • Seed, Funding Round, Series A
  • Israel, United Kingdom, Estonia

Portfolio highlights

  • EnduroSat — EnduroSat designs, builds and operates class-leading NanoSats for a range of commercial, exploration and science missions. We focus on inter-satellite connectivity and space data applications
  • Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
  • GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Show more investments...

Bits x Bites
VC Fund · Shanghai, Shanghai, China · 1 investment in the past 12 months

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

Show more...

Investment focus

  • Biotechnology, Food and Beverage, Food Processing
  • Series A, Seed, Series B
  • China, Israel, Singapore

Portfolio highlights

  • Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
  • Mojia Bioscience — Mojia Bioscience is a biotechnology company.
  • Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Show more investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in the past 12 months

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Health Care, FinTech, E-Learning
  • Pre-Seed, Seed, Series A
  • Israel, United States, Norway

Portfolio highlights

  • Wisor — Propelling the supply chain industry into the digital age Wisor is a plug & play solution that provides a global automated quoting solution that allows freight forwarders to generate quotes and communicate with clients automatically Get a demo What took days now takes minutes Wisor is specifically designed to support and simplify the complexity of generating quotes
  • Peech — Peech, an automatic video editing tool, analyzes the verbal content of your video, edits it into a short & catchy version and enhances it with suited visual elements that attract your audience.
  • Ritual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback
Show more investments...

NFX
VC Fund · San Francisco, California, United States · 25 investments in the past 12 months

We are a VC firm investing in pre-seed and seed stage startups. We back exceptional Founders building market-transforming companies.

Show more...

Investment focus

  • Software, Information Technology, Marketplace
  • Seed, Series A, Pre-Seed
  • United States, Israel, United Kingdom

Portfolio highlights

  • OpenCover — Cover $5,000 from $1.14 per week on leading protocols including Curve, Uniswap, Aave and more. As seen on CoinDesk, Decrypt, The Block, Coin Telegraph.
  • Gizmo — AI quizzes that help you learn and remember anything
  • Stoke Space — STOKE Space Technologies seamlessly connecting earth and space.
Show more investments...

Jerusalem Global Ventures
VC Fund · Jerusalem, Yerushalayim, Israel

Since the firm was founded in 1994, Jerusalem Global's goal has been to support private Israeli technology initiatives and to generate superior returns to investors. Over the last two decades, the partners of Jerusalem Global Ventures have developed strong ties with the top Israeli entrepreneurs and visionaries enabling JGV to invest in thebest of Israel's entrepreneurs and help their portfolio companies build winning management teams.

Show more...

Investment focus

  • Software, Information Technology, Biotechnology
  • Series A, Series B, Series C
  • United States, Israel, Canada

Portfolio highlights

  • Moovit — Utilizing the power of MaaS, we're helping cities, transit agencies and corporations simplify urban mobility, making it more efficient, accessible and sustainable.
  • Quiet Therapeutics — Quiet Therapeutics is an emerging biotech company founded in 2010 developing a proprietary nanoparticle-based delivery system (gagomers) focused on oncology and inflammation.Based on the targeting capability of our innovative technology, the company is well positioned to expand the drug target repertoire in cancer and inflammation. The Gagomerdelivery approach enables us to target cell components that are not manageable by other therapeutic agents like small molecules or antibodies.
  • SolarEdge Technologies — Turn your businesses and homes into a sustainable energy hub with a SolarEdge inverter solution and the SolarEdge energy manager platform.
Show more investments...

HackCapital
VC Fund · Lausanne, Vaud, Switzerland · 11 investments in the past 12 months

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

Show more...

Investment focus

  • Food and Beverage, Biotechnology, Food Processing
  • Seed, Pre-Seed, Series A
  • United States, Israel, United Kingdom

Portfolio highlights

  • PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
  • WNWN Food Labs — We're WNWN Food Labs and we love food. We're creating delicious, sustainable and ethical alternatives to unsustainable and ethically dubious foods. We're starting with cacao-free chocolate. Changing chocolate? It's Win-Win #alt-chocolate #altchocolate #alt-universe #altuniverse #alt-protein
  • New School Foods — Whole-muscle, plant-based seafood
Show more investments...

ALIVE Israel HealthTech Fund
VC Fund · Tel Aviv, Tel Aviv, Israel · 6 investments in the past 12 months

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series A, Funding Round, Series B
  • Israel, United States

Portfolio highlights

  • Append Medical — Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growingsegment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.
  • Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
  • Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Show more investments...

BRM Capital
VC Fund · Herzliya, Tel Aviv, Israel · 1 investment in the past 12 months

BRM Capital is a dynamic venture capital fund investing in early stage, Israel-related software, internet infrastructure, and communication companies. Their investment focus is on the Internet, mobile and mobile applications, digital media, online services, enterprise software, and medical device sectors and they also offer flexible, streamlinedinvestment decision making.BRM headquartered in Tel Aviv, Israel enjoys a worldwide network of industry, strategic and financial experts.

Show more...

Investment focus

  • Software, Information Technology, Internet
  • Series B, Funding Round, Series A
  • United States, Israel

Portfolio highlights

  • V-Wave — V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.
  • Flytrex — Drone delivery from your favorite local restaurants and grocery stores, straight to your backyard within 5 minutes. Contact-free, lightning-fast and no tipping.
  • Exceed Talent Capital — Exceed is an innovative platform to invest, earn, engage, influence, and celebrate Talent.
Show more investments...

Good Seed Ventures
VC Fund · Rheine, Nordrhein-Westfalen, Germany · 1 investment in the past 12 months

Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.

Show more...

Investment focus

  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Series A, Pre-Seed
  • Germany, Israel, United States

Portfolio highlights

  • Perfeggt — We harness the power of plants and cutting-edge technology to crack the egg.
  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
  • Nosh Biofoods — Nosh Biofoods is a developer of traditional meat.It produces technical-functional components and nutritional protein by utilising manufacturing technologies to explore natural microbial biodiversity.
Show more investments...

RMGP Biopharma Investment Fund
VC Fund

RMGP Biopharma Investment Fund is an investment Fund

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Funding Round
  • Israel

Portfolio highlights

  • Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
  • Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
  • Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Show more investments...

Elron Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in the past 12 months

Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.

Show more...

Investment focus

  • Information Technology, Health Care, Software
  • Seed, Series A, Funding Round
  • Israel, United States, China

Portfolio highlights

  • Creednz — B2B Payments Protection using internal finance data enriched w/ externally curated intelligence, enabling informed payment decisions in RT.
  • Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
  • Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.
Show more investments...

Fortissimo Capital
VC Fund · Rosh Ha'ayin, HaMerkaz, Israel · 1 investment in the past 12 months

Fortissimo Capital is a leading private equity fund in Israel investing primarily in technology and industrial companies. We take a unique, hands-on approach to ...

Show more...

Investment focus

  • Manufacturing, Software, Information Technology
  • Funding Round, Series B, Series C
  • Israel, United States, Italy

Portfolio highlights

  • Equinom — Equinom is a fully integrated food-tech company, combining agricultural know-how, culinary expertise and deep technology to develop delicious, nutritious, affordable and sustainable non-GMO plant-based ingredients – from the ground up.Sustainable, plant-based proteins are key to feeding Earth’s 10B people by 2050 The plant-based food market grew27% in 2020 and is projected to reach $162B by 2030.The industry is unable to supply the full demand for food vs. feed For decades, crops have been farmed primarily for animal feed – not for human consumption. To be palatable in human food, these crops require extensive and expensive processing. . With limited processing facilities equipped for this use, the industry is on track to supply only 50% of projected demand for plant-based foods.What is Equinom doing about it? Equinom is using science and technology to develop superior ingredients naturally, at the source – in a fraction of the time typically required to breed new crops. Equinom crops are bred naturally, without genetic editing or modification, and are optimized to make meat and dairy analogues more delicious, nutritious, cost-effective and sustainable. Ingredients designed by deep tech to bring out nature’s best The company’s proprietary Manna™ technology platform uses AI to speed the development of superior, high-yield, non-GMO ingredients as nature intended – featuring the quality traits that satisfy consumer expectations. The technology also ensures biodiversity and climate resilience that are critical to ensure food security in light of climate change. What makes Equinom a compelling foodtech investment and collaborator? Working with great partners including Meatless Farm, Roquette with GoodMills Group., Equinom is recognized as a trusted developer and supplier of unrivaled ingredients. Prestigious strategic investors such as BASF and Roquette have helped position Equinom as one of the breakout Round C companies to fuel the worldwide surge in plant-based eating.
  • Beewise — Beewise offers robotic beehives that operate with minimal human intervention, by utilizing AI-powered precision robotics. The company's solution automates all beekeeping activities in order to increase yield, reduce colony loss, and eliminate the use of chemical pesticides. We are the first comprehensive solution that keeps bees alive, inspite of all the stressors and challenges they face, allowing them to thrive, pollinate, and produce honey.
  • GigaSpaces Technologies — GigaSpaces modernizes enterprise architectures to drive digital transformation with unparalleled speed, performance and scale.
Show more investments...

Flerie Invest
VC Fund · 1 investment in the past 12 months

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • Sweden, Israel, Iceland

Portfolio highlights

  • AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
  • XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
  • Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Show more investments...

Genesis Park
VC Fund · Houston, Texas, United States · 5 investments in the past 12 months

Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.

Show more...

Investment focus

  • Manufacturing, Health Care, Natural Resources
  • Private Equity, Debt Financing, Funding Round
  • United States, Israel

Portfolio highlights

  • The Good Feet Store — Good Feet has been helping people with foot problems feel better and get back to living their lives. Personally fit with the arch support that meets their needs. Contact us now to see the available Good Feet Arch Support!
  • WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
  • Le Sueur Incorporated — Le Sueur Incorporated is a mining & metals company offering sand casting, permanent mold, and die casting.
Show more investments...

GlenRock Israel
VC Fund · Herzliya, Tel Aviv, Israel

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Show more...

Investment focus

  • Software, Cyber Security, Medical Device
  • Seed, Series B, Series A
  • Israel, United States

Portfolio highlights

  • Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
  • Karamba Security — Karamba Security's patented software detects and prevents cyberattacks on a wide variety of connected devices and systems, including automotive ECUs, Industry 4.0 controllers, enterprise edge devices, and IoT endpoints. Karamba's security solutions are embedded within devices and work automatically, without any need for customer operationand with negligible performance impact.
  • Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Show more investments...

Yozma Group
VC Fund · Tel Aviv, Tel Aviv, Israel

Yozma earned worldwide recognition as the founder of Israel's VC industry.

Show more...

Investment focus

  • Health Care, Medical, Software
  • Funding Round, Series B, Seed
  • Israel, United States, Australia

Portfolio highlights

  • Illumigyn — Technology that we developed, creating high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy.
  • Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
  • UltraSight — UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
Show more investments...

SCP Vitalife Partners
VC Fund · Wayne, Pennsylvania, United States

SCP Vitalife is a Life Sciences Fundformed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as seniorexecutives, clinical practitioners and venture capitalists.Their focus is on early to mid-stage life science technologies and services, with a concentration on therapeutic medical devices.They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.

Show more...

Investment focus

  • Health Care, Medical, Medical Device
  • Series C, Series D, Funding Round
  • Israel, United States

Portfolio highlights

  • MST Medical Surgery Technologies — Medical Surgery Technologies (MST) was founded in 2005 by Ziv Tamir and Moti Sholev, entrepreneurs with extensive experience in medical devices. MST leads the field of surgical analytics with its core image analytics technology designed to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery(MRCAS).  The company's core technology is a software-based image analytics information platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics. The platform is positioned to enable the operating room of the future through real-time image analytics, connectivity and automation, providing value-added functionality for surgeon, provider and patient. MST’s initial offering is AutoLap™, the only robotic image-guided laparoscope positioning system. Powered by MST’s image-analysis software, AutoLap™ interacts with the surgeon’s movements in the surgical cavity, guiding the robotic laparoscope positioner in real time, offering the surgeon full and natural control of the surgical procedure and an optimal field of view.
  • Ivenix — Ivenix, Inc. has transformed infusion delivery by designing an FDA cleared infusion system that sets new standards in usability, safety & interoperability.
  • Rewalk Robotics — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
Show more investments...

NFX Bio
VC Fund · San Francisco, California, United States

NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.Led by Omri Amirav Drory, a venture partner with NFX, who founded Genome Compiler, it helps scientists learn to be founders and guides biology companies with information technology to be a critical distinction with massiveimplications.

Show more...

Investment focus

  • Biotechnology, Therapeutics, Medical
  • Seed
  • Israel

Portfolio highlights

  • Eleven Therapeutics — Harnessing the power of combinatorial chemistry and AI to transform RNAi drug development into a programmable process.
  • Pangea Therapeutics Ltd. — Pangea provides services to Pharma/Biotech companies based on its proprietary platform.
Show more investments...

Tyson Ventures
VC Fund · Springdale, Arkansas, United States · 2 investments in the past 12 months

Tyson Ventures is the investment arm of Tyson Foods. We aim to be the strategic partner of choice for disruptive innovators transforming the food industry, and provide sustainable nutrition to a growing global population. Our current areas of interest focus on emerging proteins, technology enablers and sustainability. Let’s build the future offood... together.

Show more...

Investment focus

  • Food and Beverage, Organic Food, Biotechnology
  • Funding Round, Series B, Seed
  • United States, Israel

Portfolio highlights

  • Athian — Funding livestock sustainability via a connected carbon marketplace.
  • MycoTechnology — MycoTechnology is a food ingredient company focused on moving food forward by infusing human ingenuity with the intelligence of nature. Harnessing the power of mushrooms, MycoTechnology is able to solve some of the most pervasive challenges in the food and beverage industry.
  • Soft Robotics — Soft Robotics is an industry-leading technology company that designs and builds automated, high-speed picking solutions using proprietary soft robotic grippers, 3D machine vision, and artificial intelligence. The company's transformational robotic solutions enable system integrators and OEM machinery builders to offer solutions that automate some of the most challenging bulk processes found in food production.
Show more investments...

Amplifyher Ventures
VC Fund · New York, New York, United States

Venture capital fund investing in female founders and women leaders

Show more...

Investment focus

  • Health Care, E-Commerce, Fashion
  • Seed, Series A, Pre-Seed
  • United States, Israel

Portfolio highlights

  • AVEC — Premium, low sugar mixers made with real juice, real fruit, and all natural ingredients. Low in calorie, high in flavor. Don't compromise what you mix with your spirit.
  • Droplette — Finally, a tool to deeply infuse skin with your favorite actives. Let that sink in. Droplette makes ingredients tiny and fast to get under your skin.
  • Expressable — Expressable is an online speech therapy practice for everyone with a communication disorder. It has pioneered a parent-focused care model that uses technology and education to integrate speech therapy techniques into children's daily lives, improving outcomes and experiences.The company was founded in 2019 and is headquartered in Austin,Texas.
Show more investments...

Milk & Honey Ventures
VC Fund · 3 investments in the past 12 months

Tel-Aviv based investment firm, focused on the effective acceleration of disruptive New Protein technologies

Show more...

Investment focus

  • Biotechnology, Food and Beverage, AgTech
  • Pre-Seed, Seed
  • Israel

Portfolio highlights

  • PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
  • Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
  • Meala Foodtech — Meala Foodtech develops functional proteins for multiple meat replacements. Meala uses naturally occurring biocatalysts to treat plant-based proteins.
Show more investments...

HealthpointCapital
VC Fund · New York, New York, United States

HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.

Show more...

Investment focus

  • Medical, Biotechnology, Manufacturing
  • Series B, Series C, Funding Round
  • Israel, United States

Portfolio highlights

  • OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
  • OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!
Show more investments...

Aurum Ventures MKI
VC Fund · Ramat Gan, Tel Aviv, Israel

Morris Kahn bussiness in Aurum Ventures MKI and The Kahn Foundation an independent private philanthropic foundation.

Show more...

Investment focus

  • Biotechnology, Medical Device, Information Technology
  • Seed, Series A, Series C
  • Israel

Portfolio highlights

  • Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
  • Scopio Labs — Click here to learn more about Scopio Labs AI Driven Digital Platform for Cell Morphology.
  • KidneyCure — KidneyCure offers a novel dimension to treating advanced Chronic Kidney Disease.
Show more investments...
Investors by industry
Investors by country
VC (Venture Capital) Funds in Israel by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck